<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37552767</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1937-9145</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>797</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Science signaling</Title><ISOAbbreviation>Sci Signal</ISOAbbreviation></Journal><ArticleTitle>TGF-&#x3b2; uncouples glycolysis and inflammation in macrophages and controls survival during sepsis.</ArticleTitle><Pagination><StartPage>eade0385</StartPage><MedlinePgn>eade0385</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scisignal.ade0385</ELocationID><Abstract><AbstractText>Changes in metabolism of macrophages are required to sustain macrophage activation in response to different stimuli. We showed that the cytokine TGF-&#x3b2; (transforming growth factor-&#x3b2;) regulates glycolysis in macrophages independently of inflammatory cytokine production and affects survival in mouse models of sepsis. During macrophage activation, TGF-&#x3b2; increased the expression and activity of the glycolytic enzyme PFKL (phosphofructokinase-1 liver type) and promoted glycolysis but suppressed the production of proinflammatory cytokines. The increase in glycolysis was mediated by an mTOR-c-MYC-dependent pathway, whereas the inhibition of cytokine production was due to activation of the transcriptional coactivator SMAD3 and suppression of the activity of the proinflammatory transcription factors AP-1, NF-&#x3ba;B, and STAT1. In mice with LPS-induced endotoxemia and experimentally induced sepsis, the TGF-&#x3b2;-induced enhancement in macrophage glycolysis led to decreased survival, which was associated with increased blood coagulation. Analysis of septic patient cohorts revealed that the expression of <i>PFKL</i>, <i>TGFBRI</i> (which encodes a TGF-&#x3b2; receptor), and <i>F13A1</i> (which encodes a coagulation factor) in myeloid cells positively correlated with COVID-19 disease. Thus, these results suggest that TGF-&#x3b2; is a critical regulator of macrophage metabolism and could be a therapeutic target in patients with sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0004-3417-2481</Identifier><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Chen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6852-5661</Identifier><AffiliationInfo><Affiliation>National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowdy</LastName><ForeName>Tyrone</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Wenwen</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-7771-3058</Identifier><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Yun-Ji</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0001-5885-5771</Identifier><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pati&#xf1;o</LastName><ForeName>Liliana C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Na</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9903-1314</Identifier><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohlemacher</LastName><ForeName>Shannon I</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0003-3796-675X</Identifier><AffiliationInfo><Affiliation>Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bynum</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazmi</LastName><ForeName>Rida</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bewley</LastName><ForeName>Carole A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitrovic</LastName><ForeName>Mladen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immune Regulation Unit, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8880-9087</Identifier><AffiliationInfo><Affiliation>Genomics and Computational Biology Core, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morell</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0003-1537-7356</Identifier><AffiliationInfo><Affiliation>Genomics and Computational Biology Core, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckhaus</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Veterinary Resources, Pathology Service, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larion</LastName><ForeName>Mioara</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7016-9587</Identifier><AffiliationInfo><Affiliation>Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tussiwand</LastName><ForeName>Roxane</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1712-868X</Identifier><AffiliationInfo><Affiliation>Immune Regulation Unit, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Shea</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-6456-9752</Identifier><AffiliationInfo><Affiliation>National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>WanJun</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-9335-2114</Identifier><AffiliationInfo><Affiliation>Mucosal Immunology Section, National Institutes of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DC000086</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01 DE000101</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA DE000737</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIC DC000086</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Signal</MedlineTA><NlmUniqueID>101465400</NlmUniqueID><ISSNLinking>1945-0877</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006019" MajorTopicYN="N">Glycolysis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing Interests. The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37552767</ArticleId><ArticleId IdType="mid">NIHMS1933203</ArticleId><ArticleId IdType="pmc">PMC11145950</ArticleId><ArticleId IdType="doi">10.1126/scisignal.ade0385</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lavin Y, Mortha A, Rahman A. &amp; Merad M. Regulation of macrophage development and function in peripheral tissues. Nat Rev Immunol 15, 731&#x2013;744 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706379</ArticleId><ArticleId IdType="pubmed">26603899</ArticleId></ArticleIdList></Reference><Reference><Citation>DeNardo DG &amp; Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19, 369&#x2013;382 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7339861</ArticleId><ArticleId IdType="pubmed">30718830</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Alexander M, Misharin AV &amp; Budinger GRS The role of macrophages in the resolution of inflammation. J Clin Invest 129, 2619&#x2013;2628 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6597225</ArticleId><ArticleId IdType="pubmed">31107246</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnefoy F. et al. Factors Produced by Macrophages Eliminating Apoptotic Cells Demonstrate Pro-Resolutive Properties and Terminate Ongoing Inflammation. Front Immunol 9, 2586 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277856</ArticleId><ArticleId IdType="pubmed">30542342</ArticleId></ArticleIdList></Reference><Reference><Citation>Colegio OR et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559&#x2013;563 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301845</ArticleId><ArticleId IdType="pubmed">25043024</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray PJ et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14&#x2013;20 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4123412</ArticleId><ArticleId IdType="pubmed">25035950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossol M. et al. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 31, 379&#x2013;446 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22142165</ArticleId></ArticleIdList></Reference><Reference><Citation>Schappe MS et al. Chanzyme TRPM7 Mediates the Ca(2+) Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation. Immunity 48, 59&#x2013;74 e55 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783319</ArticleId><ArticleId IdType="pubmed">29343440</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyken SJ &amp; Locksley RM Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 31, 317&#x2013;343 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606684</ArticleId><ArticleId IdType="pubmed">23298208</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T. et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11, 936&#x2013;944 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20729857</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill LA &amp; Pearce EJ Immunometabolism governs dendritic cell and macrophage function. J Exp Med 213, 15&#x2013;23 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4710204</ArticleId><ArticleId IdType="pubmed">26694970</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell DG, Huang L. &amp; VanderVen BC Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol 19, 291&#x2013;304 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7032560</ArticleId><ArticleId IdType="pubmed">30679807</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola A, Munari F, Sanchez-Rodriguez R, Scolaro T. &amp; Castegna A. The Metabolic Signature of Macrophage Responses. Front Immunol 10, 1462 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6618143</ArticleId><ArticleId IdType="pubmed">31333642</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier T. &amp; Chen W. Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections. Front Immunol 13, 780839 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825490</ArticleId><ArticleId IdType="pubmed">35154105</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk CM et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742&#x2013;4749 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2890190</ArticleId><ArticleId IdType="pubmed">20351312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauterbach MA et al. Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase. Immunity 51, 997&#x2013;1011 e1017 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31851905</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron AM et al. Inflammatory macrophage dependence on NAD(+) salvage is a consequence of reactive oxygen species-mediated DNA damage. Nat Immunol 20, 420&#x2013;432 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30858618</ArticleId></ArticleIdList></Reference><Reference><Citation>Semba H. et al. HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity. Nat Commun 7, 11635 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873978</ArticleId><ArticleId IdType="pubmed">27189088</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC et al. Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation. Immunity 45, 817&#x2013;830 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5535820</ArticleId><ArticleId IdType="pubmed">27760338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha AK et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419&#x2013;430 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25786174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F. et al. Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation. Cell Metab 28, 463&#x2013;475 e464 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6449248</ArticleId><ArticleId IdType="pubmed">30184486</ArticleId></ArticleIdList></Reference><Reference><Citation>Vats D. et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 4, 13&#x2013;24 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1904486</ArticleId><ArticleId IdType="pubmed">16814729</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W. &amp; Ten Dijke P. Immunoregulation by members of the TGFbeta superfamily. Nat Rev Immunol 16, 723&#x2013;740 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27885276</ArticleId></ArticleIdList></Reference><Reference><Citation>Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol 13, 616&#x2013;630 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4027049</ArticleId><ArticleId IdType="pubmed">22992590</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MO &amp; Flavell RA TGF-beta: a master of all T cell trades. Cell 134, 392&#x2013;404 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677783</ArticleId><ArticleId IdType="pubmed">18692464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W. et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198, 1875&#x2013;1886 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2194145</ArticleId><ArticleId IdType="pubmed">14676299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y. et al. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 9, 632&#x2013;640 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18438410</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantini MC et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172, 5149&#x2013;5153 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15100250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier T. &amp; Chen W. IFN-gamma and TGF-beta, Crucial Players in Immune Responses: A Tribute to Howard Young. J Interferon Cytokine Res 42, 643&#x2013;654 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917322</ArticleId><ArticleId IdType="pubmed">36516375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardalhon V. et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(&#x2212;) effector T cells. Nat Immunol 9, 1347&#x2013;1355 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999006</ArticleId><ArticleId IdType="pubmed">18997793</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen M. et al. Transforming growth factor-beta &#x2018;reprograms&#x2019; the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9, 1341&#x2013;1346 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18931678</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsunawaki S, Sporn M, Ding A. &amp; Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 334, 260&#x2013;262 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3041283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl SM et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 84, 5788&#x2013;5792 (1987).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC298948</ArticleId><ArticleId IdType="pubmed">2886992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X. et al. The Cytokine TGF-beta Promotes the Development and Homeostasis of Alveolar Macrophages. Immunity 47, 903&#x2013;912 e904 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29126797</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O. et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17, 131&#x2013;143 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y. et al. A Milieu Molecule for TGF-beta Required for Microglia Function in the Nervous System. Cell 174, 156&#x2013;171 e116 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6089614</ArticleId><ArticleId IdType="pubmed">29909984</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor RA et al. TGF-beta1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Invest 127, 280&#x2013;292 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5199690</ArticleId><ArticleId IdType="pubmed">27893460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoller T. et al. Silencing of TGFbeta signalling in microglia results in impaired homeostasis. Nat Commun 9, 4011 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167353</ArticleId><ArticleId IdType="pubmed">30275444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong D. et al. TGFbeta signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol 13, 31 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406960</ArticleId><ArticleId IdType="pubmed">22703233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F. et al. TGF-beta induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget 7, 52294&#x2013;52306 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5239552</ArticleId><ArticleId IdType="pubmed">27418133</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K, Takeshita A. &amp; Hanazawa S. Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infect Immun 68, 2418&#x2013;2423 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC97440</ArticleId><ArticleId IdType="pubmed">10768925</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Y. et al. TGF-beta signaling in myeloid cells is required for tumor metastasis. Cancer Discov 3, 936&#x2013;951 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678771</ArticleId><ArticleId IdType="pubmed">23661553</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanders KC et al. Quantitation of TGF-beta proteins in mouse tissues shows reciprocal changes in TGF-beta1 and TGF-beta3 in normal vs neoplastic mammary epithelium. Oncotarget 7, 38164&#x2013;38179 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5122380</ArticleId><ArticleId IdType="pubmed">27203217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Luo D, Streit WJ &amp; Harrison JK TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol 133, 46&#x2013;55 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12446007</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama T. et al. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol 12, 86&#x2013;95 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140164</ArticleId><ArticleId IdType="pubmed">21131965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ween MP, Oehler MK &amp; Ricciardelli C. Transforming growth Factor-Beta-Induced Protein (TGFBI)/(betaig-H3): a matrix protein with dual functions in ovarian cancer. Int J Mol Sci 13, 10461&#x2013;10477 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431872</ArticleId><ArticleId IdType="pubmed">22949874</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Cruz P, Alisson-Silva F, Todeschini AR &amp; Dias WB Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition. Dev Dyn 247, 481&#x2013;491 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28722313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunt SY &amp; Vander Heiden MG Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27, 441&#x2013;464 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21985671</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke M, Fritsch SD, Sukhbaatar N, Hengstschlager M. &amp; Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett 591, 3089&#x2013;3103 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322652</ArticleId><ArticleId IdType="pubmed">28600802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S. et al. MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages. Cell Rep 35, 109264 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257047</ArticleId><ArticleId IdType="pubmed">34133930</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodi VL et al. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer. Mol Cancer Res 13, 923&#x2013;933 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433402</ArticleId><ArticleId IdType="pubmed">25636967</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall M. et al. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. Blood 112, 2305&#x2013;2317 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18621930</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M. &amp; van der Poll T. Coagulation and sepsis. Thromb Res 149, 38&#x2013;44 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27886531</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T. &amp; Levy JH Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation. Anesthesiology 132, 1238&#x2013;1245 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32044801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H. et al. TMEM173 Drives Lethal Coagulation in Sepsis. Cell Host Microbe 27, 556&#x2013;570 e556 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316085</ArticleId><ArticleId IdType="pubmed">32142632</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X. et al. Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure. Immunity 51, 983&#x2013;996 e986 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31836429</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes M. et al. An immune-cell signature of bacterial sepsis. Nat Med 26, 333&#x2013;340 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235950</ArticleId><ArticleId IdType="pubmed">32066974</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M. &amp; Martin JC Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20, 355&#x2013;362 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis. Cell Metab 32, 498&#x2013;499 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462530</ArticleId><ArticleId IdType="pubmed">32877692</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H. et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 136, 489&#x2013;500 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Olwal CO et al. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19. Front Immunol 12, 602848 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886971</ArticleId><ArticleId IdType="pubmed">33613574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W. A potential treatment of COVID-19 with TGF-beta blockade. Int J Biol Sci 16, 1954&#x2013;1955 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211163</ArticleId><ArticleId IdType="pubmed">32398962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Gomes M. et al. SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself. Nat Commun 12, 1961 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010106</ArticleId><ArticleId IdType="pubmed">33785765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol 22, 829&#x2013;838 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu E. et al. T Cell Receptor-Regulated TGF-beta Type I Receptor Expression Determines T Cell Quiescence and Activation. Immunity 48, 745&#x2013;759 e746 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911925</ArticleId><ArticleId IdType="pubmed">29669252</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MO, Sanjabi S. &amp; Flavell RA Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455&#x2013;471 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16973386</ArticleId></ArticleIdList></Reference><Reference><Citation>Marie JC, Liggitt D. &amp; Rudensky AY Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25, 441&#x2013;454 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16973387</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck MD, Sowell RT, Kaech SM &amp; Pearce EL Metabolic Instruction of Immunity. Cell 169, 570&#x2013;586 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5648021</ArticleId><ArticleId IdType="pubmed">28475890</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon JS et al. mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation. Cell Rep 12, 102&#x2013;115 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4858438</ArticleId><ArticleId IdType="pubmed">26119735</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan-Pena S. et al. Malonylation of GAPDH is an inflammatory signal in macrophages. Nat Commun 10, 338 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338787</ArticleId><ArticleId IdType="pubmed">30659183</ArticleId></ArticleIdList></Reference><Reference><Citation>Palsson-McDermott EM et al. Pyruvate Kinase M2 Regulates Hif-1alpha Activity and IL-1beta Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. Cell Metab 21, 347 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">29510100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ip WKE, Hoshi N, Shouval DS, Snapper S. &amp; Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356, 513&#x2013;519 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6260791</ArticleId><ArticleId IdType="pubmed">28473584</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan HH et al. GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell 178, 1231&#x2013;1244 e1211 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6863354</ArticleId><ArticleId IdType="pubmed">31402172</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis S. et al. Metabolic Adaptation Establishes Disease Tolerance to Sepsis. Cell 169, 1263&#x2013;1275 e1214 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480394</ArticleId><ArticleId IdType="pubmed">28622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A. et al. Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation. Cell 166, 1512&#x2013;1525 e1512 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555589</ArticleId><ArticleId IdType="pubmed">27610573</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali B, Ramakrishna K. &amp; Dhamoon AS Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med 7, 2050312119835043 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6429642</ArticleId><ArticleId IdType="pubmed">30915218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS et al. Sepsis and septic shock. Nat Rev Dis Primers 2, 16045 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538252</ArticleId><ArticleId IdType="pubmed">28117397</ArticleId></ArticleIdList></Reference><Reference><Citation>Batabyal R. et al. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics. Int J Obes (Lond) 45, 1163&#x2013;1169 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961323</ArticleId><ArticleId IdType="pubmed">33727631</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SA et al. Opposing functions of circadian protein DBP and atypical E2F family E2F8 in anti-tumor Th9 cell differentiation. Nat Commun 13, 6069 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9568563</ArticleId><ArticleId IdType="pubmed">36241625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lita A. et al. IDH1 mutations induce organelle defects via dysregulated phospholipids. Nat Commun 12, 614 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840755</ArticleId><ArticleId IdType="pubmed">33504762</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier T, Claude-Taupin A, Delage-Mourroux R, Boyer-Guittaut M. &amp; Hervouet E. Proximity Ligation In situ Assay is a Powerful Tool to Monitor Specific ATG Protein Interactions following Autophagy Induction. PLoS One 10, e0128701 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4452782</ArticleId><ArticleId IdType="pubmed">26034986</ArticleId></ArticleIdList></Reference><Reference><Citation>S Chan EC, Handbook of Water and Wastewater Microbiology (Academic Press, Cambridge, MA, 2003).</Citation></Reference><Reference><Citation>Reyes M. et al. An immune-cell signature of bacterial sepsis. Nat Med 26, 333&#x2013;340 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235950</ArticleId><ArticleId IdType="pubmed">32066974</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>